Sponsor Collaboration Opportunities

As part of The Guthrie Clinic, an integrated, non-profit health system serving over 1.85 million individuals across 14 counties in Northern Pennsylvania and the Southern Tier of New York, we offer a large and diverse patient population for both therapeutic and real-world evidence studies.
Our health system includes:
•    Six hospital campuses (including our flagship, Guthrie Robert Packer Hospital, in Sayre, Pa.)
•    Over 75 regional offices
•    10 residency and five fellowship programs fostering an academic, research-driven culture

We are currently seeking collaboration opportunities in:
•    Endocrinology: Diabetes, obesity, thyroid disorders
•    Cardiology and Invasive Cardiology: Heart failure, hypertension, lipid disorders, pacemakers
•    Infectious Diseases and Vaccines
•    Oncology
•    Pulmonology: Asthma, COPD
•    Gastroenterology: IBS, IBD, C. difficile
•    Anesthesiology and Surgical Subspecialties
•    Orthopedic Surgery

Guthrie’s regional patient base provides a unique opportunity for real-world studies:
•    57% reside in rural areas
•    High prevalence of obesity (30.6%) and diabetes (9.3%)
•    Stable and growing population with positive net migration since 2021
•    High market penetration: 27% inpatient and 30% outpatient share
•    Strong referral networks across specialties
This translates into rapid enrollment, low loss-to-follow-up, and robust data collection.

Our comprehensive research environment includes:
•    Experienced clinical investigators and certified study coordinators
•    Dedicated clinical research center with temperature-monitored storage, sample processing and secure EDC access
•    Epic EMR – Gold Star Level 10 (Top 5 nationally)
•    AAHRPP-accredited local IRB (since 2011) and central IRB support
•    Clean audit history and FDA inspection completed (EIR received April 2025)
Our integrated systems and academic setting enable high-quality, compliant studies across a wide range of therapeutic areas.

•    Proven track record of timely enrollment and retention
•    Access to treatment-naive rural populations
•    Longitudinal follow-up feasibility through stable regional demographics
•    Deep community trust and sponsor responsiveness
•    Commitment to regulatory compliance, data integrity and scientific rigor